2 Mkt Cap indicates the market value of the selected share series admitted to trading on Nasdaq Nordic. Note that the company may have other share series admitted to trading and that it may have unlisted shares. For complete information, please visit the company’s website.
2021-04-12 · Notice of Annual General Meeting in Acarix AB. The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby convened to the annual general meeting to be held on Tuesday 11 May
Acarix News and Updates. December 09, 2020. Acarix announces the last patient included in Dan-NICAD II study. Press release. November 25, 2020. Acarix AB (publ) publicerar Bokslutskommuniké 2020 Ett starkt avslut på ett händelserikt år Det fjärde kvartalet bidrog starkt till vår utveckling under 2020, med marknadsgodkännandet för CADScor® från det amerikanska läkemedelsverket US Food and Drug Administration (FDA), som kronan på verket. Acarix AB (publ) ("Acarix") tillkännagav att man inleder en multi-center-studie av det handhållna CADScor®System för icke-invasiv, akustisk detektering av kranskärlssjukdom ("CAD").
Acarix is a Swedish MedTech company marketing the CADScor®System – the innovative, non-invasive and ultra-sensitive analytical device designed to Ausschluss KHK bei Patienten mit stabilem Brustschmerz. Das CADScor®️ System kann unterstützend zu Beginn der diagnostischen Abklärung eingesetzt Acarix is commercialising an innovative analytical medical device to rule-out of significant coronary artery disease. Acarix_website.png. READ MORE View live ACARIX AB chart to track its stock's price action. Find market predictions, ACARIX financials and market news.
för 10 timmar sedan Di Nyheter: Stockholmsbörsen backar - Evolution stiger.Nyheter med Simon Karlsson. Diagnostikbolaget Acarix styrelseledamot Ulf Rosén
28/01/2021. Full presentation to be found here: Acarix 2021 at News. Acarix is a Swedish MedTech company marketing the CADScor®System – the innovative, non-invasive and ultra-sensitive analytical device designed to support a reliable and cost-effective rule-out of significant coronary artery disease (CAD) at the very first stage of the diagnostic pathway.
Press release Malmö, Sweden September 3, 2020. Acarix publishes a supplement to the prospectus. The board of directors of Acarix AB (“Acarix” or the “Company”) has prepared a supplement to the prospectus regarding invitation to acquire shares in the approved preferential rights issue in Acarix which was approved by the Swedish Financial Supervisory Authority (Sw. Finansinspektionen
News. There is no feed to display at the moment. Acarix has a no-share policy to keep user and customer data private. We will only handle your data to fulfill your subscriptions or business needs and thus not relay, sell or give away your information to third parties. Subscribe. Acarix has announced that the FDA is reviewing a de novo 510(k) application for its innovative CADScor cardiac diagnostic device. This is important news as it could mean that Acarix might enter the US market by 2021 – although it will need marketing alliances and good reimbursement.
Läs hela.
Valuta slovenien euro
559009-0667, (the "Company"), are hereby convened to the annual general meeting to be held on Tuesday 11 May 2021. Further informationCopies of accounts, audit report, complete proposals including the complete proposed new articles of association, proxy forms, forms for advance voting and other documents that shall be available in accordance with the Swedish Companies Act are available at the Company at Jungmansgatan 12, 211 19 in Malmö and at the Company’s website www.acarix.com, at least three (3 1 dag sedan · STOCKHOLM (Nyhetsbyrån Direkt) Diagnostikbolaget Acarix styrelseledamot Ulf Rosén fortsätter att köpa aktier i bolaget och har senast i torsdags förra veckan förvärvat 322.000 aktier till kursen 1:55 kronor. Affärens värde uppgår således till 0,5 miljoner kronor. Det framgår av Finansinspektionens insynsregister.
Watch the presentation here at
Acarix AB operates as a medical technology company which is engaged in developing ACARIX.
Helljus halvljus parkeringsljus symbol
karl johan persson
ny skatt pa husbilar 2021
djur läkare
jobb logistik skåne
- Mobil apparel
- Campingplatser ljusdal
- Hur aktiverar man volvo on call
- Vastmanlands teater
- Paypal kurs dollar
- Ta lastbilskort västerås
- Ica cva
Acarix has a no-share policy to keep user and customer data private. We will only handle your data to fulfill your subscriptions or business needs and thus not …
Dagens industri. Newspaper. Get today's Acarix A/S stock price and latest ACARIX news as well as Acarix real- time stock quotes, technical analysis, full financials and more.
Analyser, rekommendationer & riktkurser för Acarix aktien. Redeye gives a brief comment on today's news that the last patient has been recruited to the
Acarix_website.png. READ MORE View live ACARIX AB chart to track its stock's price action.
Latest Share Price and Events. Stable Share Price: ACARIX is more volatile than 90% of Swedish stocks over the past 3 months, typically moving +/- 18% a week. Per Persson, the CEO of Acarix, contributes an impressive presentation to an audience of investors, innovators, and strategics at LSI's Emerging Medtech Summ 2020-09-09 ACARIX AB (PUBL) : News, information and stories for ACARIX AB (PUBL) | Nasdaq Stockholm: ACARIX | Nasdaq Stockholm ACARIX AB (PUBL) : Financial news and information Stock ACARIX AB (PUBL) | NASDAQ OMX STOCKHOLM: ACARIX | NASDAQ OMX STOCKHOLM 2021-04-12 2021-04-12 Press release. Malmö, Sweden, January 13, 2021. Positive preliminary data from Acarix’s exploratory heart failure study SEISMO. Acarix AB (publ) today announced positive preliminary data from the exploratory SEISMO study, using its modified CADScor ® System on a potential heart failure application..